1. Home
  2. PBYI vs TOYO Comparison

PBYI vs TOYO Comparison

Compare PBYI & TOYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBYI
  • TOYO
  • Stock Information
  • Founded
  • PBYI 2010
  • TOYO 2022
  • Country
  • PBYI United States
  • TOYO Japan
  • Employees
  • PBYI N/A
  • TOYO N/A
  • Industry
  • PBYI Biotechnology: Pharmaceutical Preparations
  • TOYO
  • Sector
  • PBYI Health Care
  • TOYO
  • Exchange
  • PBYI Nasdaq
  • TOYO NYSE
  • Market Cap
  • PBYI 126.5M
  • TOYO 115.2M
  • IPO Year
  • PBYI N/A
  • TOYO N/A
  • Fundamental
  • Price
  • PBYI $2.42
  • TOYO $3.04
  • Analyst Decision
  • PBYI Strong Buy
  • TOYO
  • Analyst Count
  • PBYI 1
  • TOYO 0
  • Target Price
  • PBYI $7.00
  • TOYO N/A
  • AVG Volume (30 Days)
  • PBYI 524.8K
  • TOYO 23.4K
  • Earning Date
  • PBYI 11-07-2024
  • TOYO 08-21-2024
  • Dividend Yield
  • PBYI N/A
  • TOYO N/A
  • EPS Growth
  • PBYI 492.79
  • TOYO N/A
  • EPS
  • PBYI 0.47
  • TOYO 0.76
  • Revenue
  • PBYI $243,569,000.00
  • TOYO $200,455,385.00
  • Revenue This Year
  • PBYI N/A
  • TOYO N/A
  • Revenue Next Year
  • PBYI N/A
  • TOYO N/A
  • P/E Ratio
  • PBYI $5.20
  • TOYO $3.97
  • Revenue Growth
  • PBYI 6.30
  • TOYO N/A
  • 52 Week Low
  • PBYI $2.23
  • TOYO $1.36
  • 52 Week High
  • PBYI $7.73
  • TOYO $15.61
  • Technical
  • Relative Strength Index (RSI)
  • PBYI 36.08
  • TOYO N/A
  • Support Level
  • PBYI $2.83
  • TOYO N/A
  • Resistance Level
  • PBYI $3.25
  • TOYO N/A
  • Average True Range (ATR)
  • PBYI 0.29
  • TOYO 0.00
  • MACD
  • PBYI -0.04
  • TOYO 0.00
  • Stochastic Oscillator
  • PBYI 6.03
  • TOYO 0.00

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

About TOYO TOYO CO LTD

Toyo Co Ltd along with its subsidiaries is engaged in research and development, production, and sales of solar cells.

Share on Social Networks: